In addition to complex government investigations into issues of fraud and bribery in the healthcare industry, our teams work on healthcare regulatory pricing and reimbursement issues, disputes arising from healthcare M&A and joint business ventures, healthcare competition matters, FDA and medical product liability matters, healthcare commercial disputes and damages, healthcare business valuations, healthcare economics and outcomes research, and compliance issues for life sciences companies, healthcare providers, and health insurance companies. Our experts and academic affiliates have testified in some of the largest and most significant antitrust matters of the past two decades, including antitrust actions involving platforms and multi-sided markets, automobile manufacturers, insurance companies, financial markets (e.g., LIBOR and foreign exchange) and other industries.